Biology and treatment of multiple myeloma
- 31 March 1993
- journal article
- review article
- Published by Elsevier BV in Blood Reviews
- Vol. 7 (1), 24-33
- https://doi.org/10.1016/0268-960x(93)90021-u
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Second and third responses to the same induction regimen in relapsing patients with multiple myelomaCancer, 1991
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- Biologic and clinical significance of cytokine production in B‐cell malignanciesEuropean Journal of Haematology, 1989
- INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMAThe Lancet, 1989
- Peptichemio in pretreated patients with plasmacell neoplasmsEuropean Journal of Cancer and Clinical Oncology, 1986
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Tumor growth stimulation in vitro by interferonsEuropean Journal of Cancer and Clinical Oncology, 1983
- Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimensJAMA, 1969
- Cyclophosphamide vs melphalan in treatment of plasma cell myelomaPublished by American Medical Association (AMA) ,1969